摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

methyl (2Z,5R)-5-t-butyldimethylsiloxy-2-hexenoate | 133522-11-9

中文名称
——
中文别名
——
英文名称
methyl (2Z,5R)-5-t-butyldimethylsiloxy-2-hexenoate
英文别名
methyl (Z,5R)-5-[tert-butyl(dimethyl)silyl]oxyhex-2-enoate
methyl (2Z,5R)-5-t-butyldimethylsiloxy-2-hexenoate化学式
CAS
133522-11-9
化学式
C13H26O3Si
mdl
——
分子量
258.433
InChiKey
JZACRADDHGBASF-HIJJYWJESA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.52
  • 重原子数:
    17
  • 可旋转键数:
    7
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.77
  • 拓扑面积:
    35.5
  • 氢给体数:
    0
  • 氢受体数:
    3

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    methyl (2Z,5R)-5-t-butyldimethylsiloxy-2-hexenoate 在 lithium hydroxide 作用下, 以 四氢呋喃 为溶剂, 反应 18.0h, 以100%的产率得到(5R,2E)-5-(tert-butyl-dimethyl-silyloxy)-hex-2-enoic acid
    参考文献:
    名称:
    Formal total synthesis of grahamimycin A1
    摘要:
    (S)-t-Butyldimethylsiloxy-2-hexenoic acid and its (R)-isomer were prepared from (S)- and (R)-3-hydroxybutanoic acid esters, respectively. Condensation of the both isomers with 2-(ptoluenesulfonyl)ethyl (4S,5S,7R)-7-hydroxy-4,5-dimethylmethylenedioxyoctanoate, synthesized from methyl 4,6-dideoxy -alpha-D-xylo-hexopyranoside, gave the corresponding esters which were converted into precursors of seco acids of grahamimycin A1 with S or R configuration at the C-6 position (grahamimycin A1 numbering). The (6S)- and (6R)-isomers were respectively subjected to macrolactonization by the use of diethyl azodicarboxylate-triphenylphosphine system or Yamaguchi procedure to afford 11, 12-dihydroxy-grahamimycin A1 whose oxidation to grahamimycin A1 has already been reported.
    DOI:
    10.1016/s0040-4039(00)79484-6
  • 作为产物:
    参考文献:
    名称:
    Grahamimycin A1的全合成
    摘要:
    (3R)- 和 (3S)-3-羟基丁酸酯分别转化为 (2E,5R)- 和 (2E,5S)-5-t-丁基二甲基甲硅烷氧基-2-己烯酸,对应于 O-1-C-6 Grahamimycin A1 (1) 的片段。O-7–C-14 片段 [(4S,5S,7R)- 或 (4R,5R,7R)-7-hydroxy-4,5-isopropylidenedioxyoctanoate] 由 4,6-dideoxy-α-D-合成木糖苷。两个片段的缩合,然后在末端羟基和羧基官能团上脱保护得到前体 1 的 seco 酸。 而具有 13S-构型的 seco 酸与偶氮二羧酸二乙酯和三苯基膦的反应在低浓度下提供相应的内酯产率,具有 13R-构型的癸二酸通过 Yamaguchi 程序的大环内酯化以 56% 的产率得到所需的内酯。
    DOI:
    10.1246/bcsj.66.523
点击查看最新优质反应信息

文献信息

  • A Cautionary Tale in Decanolide Synthesis
    作者:Christine Willis、Thomas Simpson、Florilène Soulas
    DOI:10.1055/s-2008-1078031
    日期:2008.8
    An efficient convergent approach to the synthesis of the novel dioxolenone alcohol 3 is described and on thermolysis of 3 a macrodiolide, 12, was obtained via an intermediate β-acyl ketene. Macrodiolide 16 was obtained on thermolysis of the known dioxolenone alcohol 2 rather than the decanolide, diplodialide A.
    本文介绍了一种合成新型二氧戊烯酮醇 3 的高效聚合方法,在热分解 3 的过程中,通过中间体δ-乙酰酮烯获得了大环内酯 12。通过热分解已知的二氧杂环戊烯醇 2 而不是癸内酯--二茂烷基二内酯 A,得到了大环内酯 16。
  • Two Approaches to the Synthesis of the Macrodiolide Colletotriene
    作者:Dulce M. Muñoz、Stephen C. Passey、Thomas J. Simpson、Christine L. Willis、John B. Campbell、Richard Rosser
    DOI:10.1071/ch04038
    日期:——

    The first total syntheses of the 14-membered ring macrodilactone colletotriene are described. Starting from ethyl (R)-3-hydroxybutanoate, two synthetic strategies are compared which will enable the incorporation of deuterium at non-exchangeable sites for biosynthetic studies.

    本文介绍了 14 元环大内酯可乐三烯的首次全合成。以(R)-3-羟基丁酸乙酯为起点,比较了两种合成策略,这两种策略可以在非交换位点加入氘,用于生物合成研究。
  • Total Synthesis of Grahamimycin A<sub>1</sub>
    作者:Kazuo Ohta、Osamu Miyagawa、Hironori Tsutsui、Oyo Mitsunobu
    DOI:10.1246/bcsj.66.523
    日期:1993.2
    grahamimycin A1 (1). The O-7–C-14 fragment [(4S,5S,7R)- or (4R,5R,7R)-7-hydroxy-4,5-isopropylidenedioxyoctanoate] was synthesized from 4,6-dideoxy-α-D-xylo -hexopyranoside. Condensation of the both fragments, followed by deprotection at the terminal hydroxyl- and carboxyl-functions afforded the seco acids of the precursors of 1. While the reaction of the seco acids having 13S-configuration with diethyl azodicarboxylate
    (3R)- 和 (3S)-3-羟基丁酸酯分别转化为 (2E,5R)- 和 (2E,5S)-5-t-丁基二甲基甲硅烷氧基-2-己烯酸,对应于 O-1-C-6 Grahamimycin A1 (1) 的片段。O-7–C-14 片段 [(4S,5S,7R)- 或 (4R,5R,7R)-7-hydroxy-4,5-isopropylidenedioxyoctanoate] 由 4,6-dideoxy-α-D-合成木糖苷。两个片段的缩合,然后在末端羟基和羧基官能团上脱保护得到前体 1 的 seco 酸。 而具有 13S-构型的 seco 酸与偶氮二羧酸二乙酯和三苯基膦的反应在低浓度下提供相应的内酯产率,具有 13R-构型的癸二酸通过 Yamaguchi 程序的大环内酯化以 56% 的产率得到所需的内酯。
  • Formal total synthesis of grahamimycin A1
    作者:Kazuo Ohta、Oyo Mitsunobu
    DOI:10.1016/s0040-4039(00)79484-6
    日期:1991.1
    (S)-t-Butyldimethylsiloxy-2-hexenoic acid and its (R)-isomer were prepared from (S)- and (R)-3-hydroxybutanoic acid esters, respectively. Condensation of the both isomers with 2-(ptoluenesulfonyl)ethyl (4S,5S,7R)-7-hydroxy-4,5-dimethylmethylenedioxyoctanoate, synthesized from methyl 4,6-dideoxy -alpha-D-xylo-hexopyranoside, gave the corresponding esters which were converted into precursors of seco acids of grahamimycin A1 with S or R configuration at the C-6 position (grahamimycin A1 numbering). The (6S)- and (6R)-isomers were respectively subjected to macrolactonization by the use of diethyl azodicarboxylate-triphenylphosphine system or Yamaguchi procedure to afford 11, 12-dihydroxy-grahamimycin A1 whose oxidation to grahamimycin A1 has already been reported.
查看更多